Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paxton Bach

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
BMJ Open|March 5, 2025
Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelinesMd Belal Hossain, Brenda Carolina Guerra-Alejos, Megan Kurz, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 3, 2025
Igor Yakovenko, Yvette Mukaneza, Katuschia Germé, et al.
Addiction (Abingdon, England)|October 26, 2023
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trialsHeidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Journal of Substance Use and Addiction Treatment|September 28, 2024
Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkageBrittany B Dennis, Glenda Babe, Anastasia Gayowsky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 12, 2024
Management of opioid use disorder: 2024 update to the national clinical practice guidelineIgor Yakovenko, Yvette Mukaneza, Katuschia Germé, et al.
Drug and Alcohol Dependence Reports|August 21, 2025
Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort studyPaige Guyatt, Glenda Babe, Anastasia Gayowsky, et al.
Addiction (Abingdon, England)|August 31, 2025
Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, CanadaMegan Kurz, Brenda Carolina Guerra-Alejos, Jeong Eun Min, et al.
BMJ Open|April 29, 2024
What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, CanadaRuyu Yan, Megan Kurz, B Carolina Guerra-Alejos, et al.
BMJ Open|September 27, 2022
Advancing virtual primary care for people with opioid use disorder (VPC OUD): a mixed-methods study protocolLindsay Hedden, Rita K McCracken, Sarah Spencer, et al.
International Journal of Mental Health and Addiction|December 15, 2025
Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized TrialsMalahat Khalili, Behnam Sadeghirad, Paxton Bach, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
BMJ Open|March 5, 2025
Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelinesMd Belal Hossain, Brenda Carolina Guerra-Alejos, Megan Kurz, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 3, 2025
Igor Yakovenko, Yvette Mukaneza, Katuschia Germé, et al.
Addiction (Abingdon, England)|October 26, 2023
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trialsHeidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Journal of Substance Use and Addiction Treatment|September 28, 2024
Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkageBrittany B Dennis, Glenda Babe, Anastasia Gayowsky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 12, 2024
Management of opioid use disorder: 2024 update to the national clinical practice guidelineIgor Yakovenko, Yvette Mukaneza, Katuschia Germé, et al.
Drug and Alcohol Dependence Reports|August 21, 2025
Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort studyPaige Guyatt, Glenda Babe, Anastasia Gayowsky, et al.
Addiction (Abingdon, England)|August 31, 2025
Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, CanadaMegan Kurz, Brenda Carolina Guerra-Alejos, Jeong Eun Min, et al.
BMJ Open|April 29, 2024
What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, CanadaRuyu Yan, Megan Kurz, B Carolina Guerra-Alejos, et al.
BMJ Open|September 27, 2022
Advancing virtual primary care for people with opioid use disorder (VPC OUD): a mixed-methods study protocolLindsay Hedden, Rita K McCracken, Sarah Spencer, et al.
International Journal of Mental Health and Addiction|December 15, 2025
Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized TrialsMalahat Khalili, Behnam Sadeghirad, Paxton Bach, et al.
Pageof 9